Skip to content
← Back to this collection

PUBLICATIONS · 15231574

Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2004 Nov 1
First author
Champagne MA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Champagne MA
      type
      Author
    2. name
      Capdeville R
      type
      Author
    3. name
      Krailo M
      type
      Author
    4. name
      Qu W
      type
      Author
    5. name
      Peng B
      type
      Author
    6. name
      Rosamilia M
      type
      Author
    7. name
      Therrien M
      type
      Author
    8. name
      Zoellner U
      type
      Author
    9. name
      Blaney SM
      type
      Author
    10. name
      Bernstein M
      type
      Author
    11. name
      Children's Oncology Group phase 1 study
      type
      CollectiveName
    Complete bibliographic record and source provenance
    authors
    1. name
      Champagne MA
      type
      Author
    2. name
      Capdeville R
      type
      Author
    3. name
      Krailo M
      type
      Author
    4. name
      Qu W
      type
      Author
    5. name
      Peng B
      type
      Author
    6. name
      Rosamilia M
      type
      Author
    7. name
      Therrien M
      type
      Author
    8. name
      Zoellner U
      type
      Author
    9. name
      Blaney SM
      type
      Author
    10. name
      Bernstein M
      type
      Author
    11. name
      Children's Oncology Group phase 1 study
      type
      CollectiveName
    bibliography ids
    1. nci-bib-62ec02e5525357650b36c3f6
    book metadata
    content sha256
    0cf63f08db735d612d9dd3748d03aa2b529872bb30e50951b25f02ca3fa22849
    document type
    citation
    dois
    1. 10.1182/blood-2003-09-3032
    electronic publication date
    display
    2004 Jul 1
    precision
    day
    year
    2004
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:15231574
    immutable id
    pubmed:15231574@0cf63f08db735d612d9dd3748d03aa2b529872bb30e50951b25f02ca3fa22849
    journal
    abbreviation
    Blood
    issn electronic
    Source null
    issn print
    0006-4971
    issue
    9
    name
    Blood
    nlm unique id
    7603509
    pages
    2655-60
    volume
    104
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      15231574
      provenance
      batch id
      748437a772c9631ad901
      provider
      NCBI PubMed ESummary
      record sha256
      ec9d895b39f2a2153ba9a2a587c3b6f60b5298dab319e74867a497e59731d2d5
      response sha256
      1535c16de1ca2ef53b01ccf9e7709049035aa1b159955f06fbec3d1a0daddc80
      retrieved at
      2026-09-09T23:45:55.399079+00:00
      publication date
      display
      2004 Nov 1
      precision
      day
      year
      2004
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase I
      3. Journal Article
      4. Multicenter Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/15231574/
      title
      Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study.

      Preserved source evidence · Not medical advice